Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 11, 2026
Empirical Antibiotic Activity and Outcomes in Pediatric Gram-Negative Bloodstream Infections: A Rank-based Composite Outcome AnalysisSophie C H Wen, Melissa J Hardy, Abdullah T Aslan, et al.
The Lancet. Infectious Diseases|June 30, 2022
Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trialsAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2024
Characterization of Gram-negative Bloodstream Infections in Hospitalized Australian Children and Their Clinical OutcomesSophie C H Wen, Patrick N A Harris, Brian Forde, et al.
Frontiers in Pediatrics|February 3, 2022
Study Protocol for Preventing Early-Onset Pneumonia in Young Children Through Maternal Immunisation: A Multi-Centre Randomised Controlled Trial (PneuMatters)Anne B Chang, Maree Toombs, Mark D Chatfield, et al.
Plos Medicine|June 3, 2024
Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedulesAmanda Jane Leach, Nicole Wilson, Beth Arrowsmith, et al.
BMJ Open|February 5, 2025
Azithromycin to prevent acute lower respiratory infections among Australian and New Zealand First Nations and Timorese children (PETAL trial): study protocol for a multicentre, international, double-blind, randomised controlled trialGabrielle B McCallum, Catherine A Byrnes, Peter S Morris, et al.
BMJ Open Respiratory Research|May 8, 2024
Erdosteine in children and adults with bronchiectasis (BETTER trial): study protocol for a multicentre, double-blind, randomised controlled trialAnne B Chang, Stephanie T Yerkovich, Katherine J Baines, et al.
Plos Medicine|October 5, 2018
Correction: Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
Plos Medicine|May 17, 2017
Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trialTesfay Abreha, Jimee Hwang, Kamala Thriemer, et al.
BMJ Open Respiratory Research|May 9, 2022
Reducing exacerbations in children and adults with primary ciliary dyskinesia using erdosteine and/or azithromycin therapy (REPEAT trial): study protocol for a multicentre, double-blind, double-dummy, 2×2 partial factorial, randomised controlled trialAnne B Chang, Lucy C Morgan, Emma L Duncan, et al.
Pageof 15